Pansakorn Tanratana
Overview
Explore the profile of Pansakorn Tanratana including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tanratana P, Seanoon K, Payongsri P, Kadegasem P, Chuansumrit A, Sirachainan N
Thromb Haemost
. 2024 Sep;
PMID: 39227034
Background: Protein C (PC) deficiency is a well-established risk factor for thromboembolism (TE), commonly manifesting in pediatric patients. This study aimed to elucidate the pathogenic mechanisms of two novel PC...
2.
Seanoon K, Kitiyanant V, Payongsri P, Sirachainan N, Angchaisuksiri P, Chuansumrit A, et al.
Res Pract Thromb Haemost
. 2024 Feb;
8(1):102309.
PMID: 38318153
Background: Recombinant factor (F)VIIa (rFVIIa) has been approved by the US Food and Drug Administration for the treatment of hemophilia A and B with inhibitors and congenital FVII deficiency. Moreover,...
3.
Tanratana P, Sachetto A, Mast A, Mackman N
Res Pract Thromb Haemost
. 2024 Jan;
8(1):102275.
PMID: 38187825
No abstract available.
4.
Saardpun N, Songsaeng R, Tanratana P, Kusamran T, Pinthong D
Molecules
. 2023 Jun;
28(12).
PMID: 37375127
Triptorelin and leuprorelin are synthetic gonadotrophin-releasing hormones (GnRH) that are on the World Anti-Doping Agency (WADA) list of prohibited substances. To investigate the possible in vivo metabolites of triptorelin and...
5.
Tanratana P, Sachetto A, Mackman N
J Thromb Haemost
. 2023 Mar;
21(4):1059-1061.
PMID: 36990515
No abstract available.
6.
Grover S, Kawano T, Wan J, Tanratana P, Polai Z, Shim Y, et al.
Blood
. 2023 Jan;
141(19):2390-2401.
PMID: 36701760
C1 inhibitor (C1INH) is a multifunctional serine protease inhibitor that functions as a major negative regulator of several biological pathways, including the contact pathway of blood coagulation. In humans, congenital...
7.
Wan J, Tanratana P, Roest M, Gruber A, Pawlinski R, Wolberg A, et al.
Blood Adv
. 2022 Dec;
7(9):1915-1925.
PMID: 36583671
Thrombin generation (TG) assays serve as a valuable tool to study the amplifying roles of intrinsic pathway factors in human coagulation and provide functional insights into the increased bleeding observed...
8.
Vachiramon V, Tanratana P, Anuntrangsee T, Palakornkitti P, Yeesibsean N, Kungvalpivat P, et al.
Skin Res Technol
. 2022 Nov;
29(1):e13240.
PMID: 36382669
Background: The transient receptor potential vanilloid 1 (TRPV1) provides a heat and pain sensation (nociception). Capsaicin, a TRPV1 agonist, has been shown to induce a refractory period in the nerve...
9.
Seanoon K, Payongsri P, Vivithanaporn P, Sirachainan N, Chuansumrit A, Hongeng S, et al.
Blood Adv
. 2022 Aug;
6(22):5887-5897.
PMID: 35973191
Tissue factor (TF) pathway inhibitor (TFPI) is a Kunitz-type anticoagulation protein that inhibits activated factor VII (FVIIa)/TF complex. Incidentally, many different F7 gene variants, including TFPI-binding exosite mutations, have been...
10.
Pongjantarasatian S, Kadegasem P, Sasanakul W, Sa-Ngiamsuntorn K, Borwornpinyo S, Sirachainan N, et al.
PLoS One
. 2019 Aug;
14(8):e0220825.
PMID: 31381603
Human mesenchymal stem cells (hMSCs) have the potential to differentiate into hepatocyte-like cells, indicating that these cells may be the new target cell of interest to produce biopharmaceuticals. Our group...